Zeda Rosenberg, Chief Executive Offiver of the International Partnership for Microbicides, says: "While there is much progress to celebrate in HIV treatment and prevention, protecting women remains a major challenge. AIDS is the number-one killer of women ages 15 to 44 worldwide. Women are biologically more vulnerable to infection and face deep-rooted gender inequities that increase their risk. In sub-Saharan Africa, where the epidemic has taken the greatest toll, young women are at least twice as likely to contract HIV as young men."
26 November 2014 | Huffington Post
A global health controversy erupted this summer when the prominent scientific journal Nature ran an article entitled “HIV trial attacked.” Within, commentators squared off over whether a huge ongoing study provides suboptimal and thus unethical treatment options to mothers with HIV in the developing world.
02 October 2014 | Health Affairs (blog)
The pain of living through the loss of three children was enough to discourage Constance Mudenda from ever contemplating parenting. When she was pregnant, her greatest desire was to have a child born free of HIV, and now she will continue to mentor her daughter to ensure she is protected from acquiring HIV.
21 August 2014 | Times of Zambia
All pregnant, HIV positive women will go onto lifelong antiretroviral treatment from January, Health Minister Dr Aaron Motsoaledi announced in his health budget vote yesterday.
24 July 2014 | AllAfrica
This is the second in a three-part series of about women and Option B+ in Africa.
"Although Swazi women have better health-seeking behaviour than men, they find it hard to deal with HIV because of socio-cultural barriers, says the study. Many HIV positive married women live in a dilemma between obeying their husbands or following the advice of the health workers."
05 June 2014 | IPS
In Uganda the prescription of three antiretroviral drugs, which aim to suppress the virus to prevent disease progression, have resulted in huge reductions in HIV mortality rates. However, disease is not the only scourge in Uganda, and a new study in The Journal of Clinical Pharmacology explores the impact food insecurity may have on treating pregnant women.
19 February 2014 | Eurekalert Medicine & Health
Wakonyo and her baby benefitted from Kenya’s successful drive to extend PMTCT, which nearly halved new infections among children between 2009 and 2011. But, worryingly, the drive is losing impetus. PMTCT coverage fell by 20 percent in 2011-2012, says the Progress Report 2013 of the Joint United Nations Programme on HIV/AIDS (UNAIDS).
29 January 2014 | Inter Press Service
Since July 2012, the Here I Am Campaign has been receiving stories from communities around the world, whose lives have been greatly impacted by the Global fund to fight AIDS, TB and Malaria. We initially set a goal to get 80 videos from around the world; we were overwhelmed by the responses.
04 December 2013 | Huffington Post
Uganda has gotten plenty of kudos and some criticism over its roll out of the new antiretroviral therapy for pregnant women and their babies, known as Option B +. Recommended by the World Health Organisation in June 2012, Option B+ consists in life-long provision of ARV therapy to pregnant women regardless of their CD4 count.
27 November 2013 | Inter Press Service
In February 2013, the Zimbabwe Ministry of Health and Child Welfare (MOHCW) decided to adopt Option B+ as its official PMTCT regimen.
10 September 2013 | Elizabeth Glaser Pediatric AIDS Foundation